Abstract
Emerging molecular and precision medicine makes nuclear medicine a de facto choice of imaging, especially in the era of target-oriented medical care. Nuclear medicine is minimally invasive, four-dimensional (space and time or dynamic space), and functional imaging using radioactive biochemical tracers in evaluating human diseases on an anatomically configured image. Many radiopharmaceuticals are also used in therapies. However, there have been concerns over the emission of radiation from the radionuclides, resulting in wrongly neglecting the potential benefits against little or any risks at all of imaging to the patients. The sound concepts of radiation and radiation protection are critical for promoting the optimal use of radiopharmaceuticals to patients, and alleviating concerns from caregivers, nuclear medicine staff, medical colleagues, and the public alike.
Funding Information
  • Ministry of Science and Technology, R.O.C. (MOST 109-2314-B-038-151, B-075-052-MY2, MOST 110-2314-B-038-167, DP2-111-21121-01-C-03-03, 110TMU-TMUH-02-3, TMU109-AE1-B27, 110-AE1-B26)
  • Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (MOST 109-2314-B-038-151, B-075-052-MY2, MOST 110-2314-B-038-167, DP2-111-21121-01-C-03-03, 110TMU-TMUH-02-3, TMU109-AE1-B27, 110-AE1-B26)
  • Taipei Medical University Hospital (MOST 109-2314-B-038-151, B-075-052-MY2, MOST 110-2314-B-038-167, DP2-111-21121-01-C-03-03, 110TMU-TMUH-02-3, TMU109-AE1-B27, 110-AE1-B26)

This publication has 34 references indexed in Scilit: